Kharkiv avenu, 50
Kiev, Ukraine 02160
Scientific Production Enterprise NIR was founded on October 23, 1992. At the moment NIR is a leading enterprise in the development of totaly new fetotherapeutic medicine direction. The company is engaged in research, development, production and introduction new medicines. NIR specialists have developed a number of pharmacological agents based on embryonic tissue of cattle. That is proved that medicines based on embryonic tissues launch underlying mechanisms of recovery, thus extending the possibilities of treatment in a wide range of pathological conditions.
Propes, Cerebrocurin, Inflamafertin are registered trademarks, which have received recognition from the experts.